Shanghai Medicilon Inc. (SHA:688202)

China flag China · Delayed Price · Currency is CNY
69.50
+1.78 (2.63%)
At close: Mar 9, 2026
99.25%
Market Cap 9.14B
Revenue (ttm) 1.08B
Net Income (ttm) -231.86M
Shares Out 131.55M
EPS (ttm) -1.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,029,495
Average Volume 3,667,045
Open 65.94
Previous Close 67.72
Day's Range 65.39 - 70.93
52-Week Range 25.10 - 84.70
Beta 1.00
RSI 57.99
Earnings Date Apr 23, 2026

About Shanghai Medicilon

Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers medicinal and analytical chemistry; process development; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and recombinant kinase preparation services, as well as... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1,717
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688202
Full Company Profile

Financial Performance

In 2024, Shanghai Medicilon's revenue was 1.04 billion, a decrease of -24.01% compared to the previous year's 1.37 billion. Losses were -330.85 million, 896.2% more than in 2023.

Financial Statements

News

There is no news available yet.